Financial Analysis: Clover Health Investments (CLOV) vs. Its Competitors
Clover Health Investments (NASDAQ:CLOV – Get Rating) is one of 13 public companies in the “Hospital & medical service plans” industry, but how does it compare to its competitors? We will compare Clover Health Investments to related companies based on the strength of its risk, profitability, dividends, valuation, earnings, institutional ownership and analyst recommendations.
Insider and Institutional Ownership
18.1% of Clover Health Investments shares are owned by institutional investors. Comparatively, 88.0% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 1.5% of shares of all “Hospital & medical service plans” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Volatility & Risk
Clover Health Investments has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500. Comparatively, Clover Health Investments’ competitors have a beta of 1.04, meaning that their average stock price is 4% more volatile than the S&P 500.
Earnings and Valuation
This table compares Clover Health Investments and its competitors revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Clover Health Investments | $1.47 billion | -$587.76 million | -2.20 |
| Clover Health Investments Competitors | $71.33 billion | $2.57 billion | 6.15 |
Clover Health Investments’ competitors have higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Profitability
This table compares Clover Health Investments and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Clover Health Investments | -39.93% | -97.71% | -45.48% |
| Clover Health Investments Competitors | -5.34% | -3.70% | -4.00% |
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Clover Health Investments and its competitors, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Clover Health Investments | 3 | 3 | 2 | 0 | 1.88 |
| Clover Health Investments Competitors | 108 | 1135 | 2309 | 51 | 2.64 |
Clover Health Investments presently has a consensus price target of $6.38, suggesting a potential upside of 103.03%. As a group, “Hospital & medical service plans” companies have a potential upside of 1.97%. Given Clover Health Investments’ higher probable upside, research analysts clearly believe Clover Health Investments is more favorable than its competitors.
Summary
Clover Health Investments competitors beat Clover Health Investments on 11 of the 13 factors compared.
Clover Health Investments Company Profile (Get Rating)
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Want More Great Investing Ideas?
Receive News & Ratings for Clover Health Investments Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Clover Health Investments and related companies with MarketBeat.com’s FREE daily email newsletter.
